- Open Access
Correction to: Down-regulated lncRNA SBF2-AS1 inhibits tumorigenesis and progression of breast cancer by sponging microRNA-143 and repressing RRS1
Journal of Experimental & Clinical Cancer Research volume 39, Article number: 60 (2020)
Correction to: J Exp Clin Cancer Res (2020) 39: 18
The original publication of this manuscript  listed the definition of RRS1 as ‘resistance to ralstonia solanacearum 1’ on four occassions. This was incorrect and RSS1 should instead be defined as ‘Ribosome biogenesis regulatory protein homolog’.
In additional, Table 1 needs to be revised as below.
The authors apologize for the inconvenience that the corrections caused.
Xia W, et al. Down-regulated lncRNA SBF2-AS1 inhibits tumorigenesis and progression of breast cancer by sponging microRNA-143 and repressing RRS1. J Exp Clin Cancer Res. 2020;39:18.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Xia, W., Liu, Y., Cheng, T. et al. Correction to: Down-regulated lncRNA SBF2-AS1 inhibits tumorigenesis and progression of breast cancer by sponging microRNA-143 and repressing RRS1. J Exp Clin Cancer Res 39, 60 (2020). https://doi.org/10.1186/s13046-020-01563-5